Patient Involvement in the Design of an Innovative Clinical Study to Compare the Palatability of Anti-Hyperkalemia Medications

References

• Yeoman G, Furlong P, Seres M, et al. Defining patient centricity with patients for patients and caregivers: a collaborative endeavour. BMJ Innov. 2017;3(2):76–83. doi:10.1136/bmjinnov-2016-000157
   PubMedGoogle Scholar
• Kaba R, Sooriakumaran P. The evolution of the doctor-patient relationship. Int J Surg. 2007;5(1):57–65. doi:10.1016/j.ijsu.2006.01.005
   PubMedGoogle Scholar
• Kilbride MK, Joffe S. The New Age of Patient Autonomy: Implications for the Patient-Physician Relationship. JAMA. 2018;320(19):1973–1974. doi:10.1001/jama.2018.14382
   PubMed Web of Science ®Google Scholar
• Taylor K. Paternalism, participation and partnership - The evolution of patient centeredness in the consultation. Patient Educ Couns. 2009;74(2):150–155. doi:10.1016/j.pec.2008.08.017
   PubMed Web of Science ®Google Scholar
• Edwards D, Best S. The Textbook of Health and Social Care. 1st ed. Sage Publications; 2020.
   Google Scholar
• Brett J, Staniszewska S, Mockford C, et al. Mapping the impact of patient and public involvement on health and social care research: a systematic review. Health Expect. 2014;17(5):637–650. doi:10.1111/j.1369-7625.2012.00795.x
   PubMed Web of Science ®Google Scholar
• The Patient-Centred Outcomes Research Institute (PCORI). The Value of Engagement in Research. Available from: https://www.pcori.org/engagement/value-engagement. Accessed May 21, 2024.
   Google Scholar
• Burke MD, Keeney M, Kleinberg R, Burlage R. Challenges and Opportunities for Patient Centric Drug Product Design: Industry Perspectives. Pharm Res. 2019;36(6):85. doi:10.1007/s11095-019-2616-5
   PubMed Web of Science ®Google Scholar
• Stergiopoulos S, Michaels DL, Kunz BL, Getz KA. Measuring the Impact of Patient Engagement and Patient Centricity in Clinical Research and Development. Ther Innov Regul Sci. 2020;54(1):103–116. doi:10.1007/s43441-019-00034-0
   PubMed Web of Science ®Google Scholar
• du Plessis D, Sake J-K, Halling K, Morgan J, Georgieva A, Bertelsen N. Patient Centricity and Pharmaceutical Companies: Is It Feasible? Ther Innov Regul Sci. 2017;51(4):460–467. doi:10.1177/2168479017696268
   PubMed Web of Science ®Google Scholar
• Dockendorf MF, Hansen BJ, Bateman KP, Moyer M, Shah JK, Shipley LA. Digitally Enabled, Patient-Centric Clinical Trials: Shifting the Drug Development Paradigm. Clin Transl Sci. 2021;14(2):445–459. doi:10.1111/cts.12910
   PubMed Web of Science ®Google Scholar
• Geißler J, Isham E, Hickey G, Ballard C, Corbett A, Lubbert C. Patient involvement in clinical trials. Communicat Med (Lond). 2022;2(1):94. doi:10.1038/s43856-022-00156-x
   PubMedGoogle Scholar
• Hoos A, Anderson J, Boutin M, et al. Partnering With Patients in the Development and Lifecycle of Medicines: A Call for Action. Ther Innov Regul Sci. 2015;49(6):929–939. doi:10.1177/2168479015580384
   PubMed Web of Science ®Google Scholar
• Smith J, Damm K, Hover G, Chien J. Lessons from an Experiential Approach to Patient Community Engagement in Rare Disease. Clin Ther. 2021;43(2):421–429. doi:10.1016/j.clinthera.2020.12.002
   PubMed Web of Science ®Google Scholar
• Leiter A, Sablinski T, Diefenbach M, et al. Use of crowdsourcing for cancer clinical trial development. J Natl Cancer Inst. 2014;106(10):dju258. doi:10.1093/jnci/dju258
   PubMedGoogle Scholar
• Levitan B, Getz K, Eisenstein EL, et al. Assessing the Financial Value of Patient Engagement:A Quantitative Approach from CTTI’s Patient Groups and Clinical Trials Project. Ther Innov Regul Sci. 2018;52(2):220–229. doi:10.1177/2168479017716715
   PubMed Web of Science ®Google Scholar
• Edwards V, Wyatt K, Logan S, Britten N. Consulting parents about the design of a randomized controlled trial of osteopathy for children with cerebral palsy. Health Expect. 2011;14(4):429–438.
   PubMed Web of Science ®Google Scholar
• Davies-Teye BB, Medeiros M, Chauhan C, Baquet CR, Mullins CD. Pragmatic patient engagement in designing pragmatic oncology clinical trials. Future Oncol. 2021;17(28):3691–3704. doi:10.2217/fon-2021-0556
   PubMed Web of Science ®Google Scholar
• The Economist Intelligence Unit. The Innovation Imperative: The Future of Drug Development Part I: Research Methods and Findings. Available from: https://druginnovation.eiu.com/wp-content/uploads/2019/05/Parexel-innovations-in-drug-development-part-1_V14.pdf. Accessed August 18, 2023.
   Google Scholar
• Menditto E, Orlando V, De Rosa G, et al. Patient Centric Pharmaceutical Drug Product Design—The Impact on Medication Adherence. Pharmaceutics. 2020;12(1):44. doi:10.3390/pharmaceutics12010044
   PubMed Web of Science ®Google Scholar
• Brixner D, Rubin DT, Mease P, et al. Patient Support Program Increased Medication Adherence with Lower Total Health Care Costs Despite Increased Drug Spending. J Manag Care Spec Pharm. 2019;25(7):770–779. doi:10.18553/jmcp.2019.18443
   PubMed Web of Science ®Google Scholar
• European Medicines Agency. Appendix 2 to the guideline on the evaluation of anticancer medicinal products in man: The use of patient-reported outcome (PRO) measures in oncology studies. Available from: https://www.ema.europa.eu/en/documents/other/appendix-2-guideline-evaluation-anticancer-medicinal-products-man_en.pdf. Accessed August 18, 2023.
   Google Scholar
• U.S. Food and Drug Administration. Principles for Selecting, Developing, Modifying, and Adapting Patient-Reported Outcome Instruments for Use in Medical Device Evaluation - Final Guidance: March 1, 2022. Available from: https://www.fda.gov/media/156929/download. Accessed August 18, 2023.
   Google Scholar
• PharmaPhorum. Patient Engagement is no longer optional. Available from: https://pharmaphorum.com/views-and-analysis/patient-engagement-is-no-longer-optional/. Accessed August 18, 2023.
   Google Scholar
• Brogan AP, DeMuro C, Barrett AM, D’Alessio D, Bal V, Hogue SL. Payer Perspectives on Patient-Reported Outcomes in Health Care Decision Making: Oncology Examples. J Manag Care Spec Pharm. 2017;23(2):125–134. doi:10.18553/jmcp.2017.23.2.125
   PubMed Web of Science ®Google Scholar
• Lubkeman M, Lee M, Barrios G. What Do Patients Want, and Is Pharma Delivering? Available from: https://www.bcg.com/publications/2020/what-patients-want-is-pharma-delivering. Accessed August 18, 2023.
   Google Scholar
• Palmer BF. Potassium Binders for Hyperkalemia in Chronic Kidney Disease—Diet, Renin-Angiotensin-Aldosterone System Inhibitor Therapy, and Hemodialysis. Mayo Clin Proc. 2020;95(2):339–354. doi:10.1016/j.mayocp.2019.05.019
   PubMed Web of Science ®Google Scholar
• Morales E, Cravedi P, Manrique J. Management of Chronic Hyperkalemia in Patients With Chronic Kidney Disease: An Old Problem With News Options. Front Med (Lausanne). 2021;8:653634. doi:10.3389/fmed.2021.653634
   PubMedGoogle Scholar
• Weir MR, Rolfe M. Potassium Homeostasis and Renin-Angiotensin-Aldosterone System Inhibitors. Clin J Am Soc Nephrol. 2010;5(3):531–548. doi:10.2215/CJN.07821109
   PubMed Web of Science ®Google Scholar
• Yu M-Y, Yeo JH, Park J-S, Lee CH, Kim G-H. Long-term efficacy of oral calcium polystyrene sulfonate for hyperkalemia in CKD patients. PLoS One. 2017;12(3):e0173542. doi:10.1371/journal.pone.0173542
   PubMed Web of Science ®Google Scholar
• Zann V, McDermott J, Jacobs JW, et al. Palatability and physical properties of potassium-binding resin RDX7675: comparison with sodium polystyrene sulfonate. Drug Des Devel Ther. 2017;11:2663–2673. doi:10.2147/DDDT.S143461
   PubMed Web of Science ®Google Scholar
• Laureati P, Xu Y, Trevisan M, et al. Initiation of sodium polystyrene sulphonate and the risk of gastrointestinal adverse events in advanced chronic kidney disease: a nationwide study. Nephrol Dial Transplant. 2020;35(9):1518–1526. doi:10.1093/ndt/gfz150
   PubMed Web of Science ®Google Scholar
• Noel JA, Bota SE, Petrcich W, et al. Risk of Hospitalization for Serious Adverse Gastrointestinal Events Associated With Sodium Polystyrene Sulfonate Use in Patients of Advanced Age. JAMA Intern Med. 2019;179(8):1025–1033. doi:10.1001/jamainternmed.2019.0631
   PubMed Web of Science ®Google Scholar
• Hsu KL, Fink JC, Ginsberg JS, et al. Self-reported Medication Adherence and Adverse Patient Safety Events in CKD. Am J Kidney Dis. 2015;66(4):621–629. doi:10.1053/j.ajkd.2015.03.026
   PubMed Web of Science ®Google Scholar